Osteoarthritis, KneeNCT06134050
Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy
A study testing Procedure: HTO using PSI aiming at 55% correction and Procedure: HTO using PSI aiming at 62% correction in people with Osteoarthritis, Knee and Knee Pain Chronic, run by Vestre Viken Hospital Trust.
Trial summary
The purpose of this RCT is to investigate whether high tibial osteotomy using 3D printed patient specific guides aiming at 55% correction is non-inferior to aiming at 62%. Read more about this study
- Who is it for?
- Ages 20 to 60 years
- Conditions the study is for
- Osteoarthritis, Knee, Knee Pain Chronic, Arthralgia
- What is being tested?
- Procedure: HTO using PSI aiming at 55% correction and Procedure: HTO using PSI aiming at 62% correction
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- No sites listed yet
- Study dates
- Nov 2023to Oct 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients having accepted and signed the informed consent form before surgery
- Patients aged 30-60 years
- Patients with an indication for primary HTO based on anamnestic, clinical and radiological findings leading to the diagnosis of major medial knee compartment overload symptoms
- Mechanical varus axis of 3-9 deg. (calculated on full length weightbearing X-ray (FLWB))
- Correctable angular deformity on the tibia only (medial proximal tibial angle (MPTA) + planned correction < 95 deg. Lateral distal femoral angle (LDFA) <92 deg.)
- Maximal calculated gap height 14 mm
- Only the first knee will be included if later contralateral HTO
Who cannot join
- Inflammatory arthritis (Rheumatoid Arthritis, Bechterew arthritis, Psoriatic Arthritis)
- Patients using Prednisolone perorally
- Smokers (need to quit preoperatively)
- Significant overweight (Body Mass Index > 35)
- Earlier fractures in affected leg with fracture malalignment >5 deg.
- Extension deficit >10 deg. in the affected knee
Show all 11Show fewer
- Earlier septic arthritis/osteomyelitis in the affected leg
- Previous major surgery affecting leg function. Earlier knee arthroscopic procedures like ACL-reconstruction are not excluded
- Planned combined procedures involving HTO + ACL/PCL-reconstruction, meniscal transplantation or meniscal root fixation is excluded
- Neurologic disease with symptoms affecting the leg
- Serious illness or other factors that make communication, follow-up or rehabilitation difficult (e.g. alcohol or drug abuse, psychiatric disease, non-Norwegian speakers).
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy Using 3D Printed Patient-specific Instrumentation (PSI). An RCT Comparing Correction Aimed at 62% Versus 55%.
The purpose of this RCT is to investigate whether high tibial osteotomy using 3D printed patient specific guides aiming at 55% correction is non-inferior to aiming at 62%.
Read the detailed description
HTO should play a major role in modern treatment algorithms for knee overload and osteoarthritis. By transferring load from the failing/osteoarthritic compartment of the knee to a healthier compartment, HTO can delay or stop the progression of osteoarthritis at an early stage. This can remove pain and increase knee function, making return to work, activities and sport possible. HTO may delay or avoid the need for total knee replacement for >10 years for at least 80% of patients.
The optimal target for the postoperative mechanical axis of the leg is not yet clarified. Both under- and overcorrection can lead to unfavourable results. The classical Fusjisawa´s point of 62%, or approximately 3 deg. of valgus, is still often used as the optimal target, and studies show good clinical results and longevity. With an often accepted accuracy of +/- 3 deg. with conventional methods, the accepted postoperative range of valgus will be from 0 deg. to 6 deg. But the optimal range is possibly much narrower. Recent studies suggest a narrower range and less overcorrection.
3D-printed patient specific instrumentation (PSI) is based on CT of the individual patient´s knee, data simulation of the planned correction and subsequent 3D printed guides for each patient. The PSI design varies, but involves a positioning guide fitting only in position one the proximal tibia, a cutting guidance and a wedge opening guide. PSI seem to improve accuracy to the level of approximately +/- 1 deg. from the preplanned correction and leads to fewer unacceptable outliers compared to the conventional methods available. Improved accuracy has not shown to yield better clinical results.
In the future the target axis should possibly be individualized, based on the pathology treated, gait analyses and data simulations.
Modern gait analysis using wearable accelerator sensors, often referred to as inertial measurement units (IMUs) is rapidly evolving. By coupling individualized and accurate osteotomy with gait analysis using wearable sensors, one could better predict and understand how to normalise each individual patients´ gait pattern and possibly improve patient satisfaction and function after surgery.
By coupling the highly accurate PSI method, an angular stable implant and a composite of outcomes based on radiology, validated patient reported outcome measures and gait analysis, our RCT can investigate if a correction target of 55% is non-inferior to the common 62%.
The study will be designed as a continuous outcome non-inferiority trial where KOOS QoL subscale is used as the primary outcome and the basis for sample size calculation. The Minimal Clinical Important Difference (MCID) for KOOS QoL regarding HTO is 16.5 points. A presumed standard deviation (SD) of 23 points is obtained from a previous study on a similar population. A one-sided t-test power analysis with 2.5% significance level and 80% power level indicates that 31 patients would be needed in each group. In total 70 patients is planned to be included, which takes into account up to 10% dropout rate and some uncertainty regarding the predicted score values.
Statistics:
The primary outcome will be analyzed with a linear mixed model, where the measurements from all time points will be included. The main effect measure will be the between-group difference in change from baseline to two years, which will be estimated with a 95% confidence interval and a P-value for non-inferiority where the null hypothesis is that osteotomy correction to the 55% target is inferior to the correction to the 62% target and the alternative states that it is not. Inferiority is determined by KOOS QOL difference of at least MCID.
Paired samples t-tests will be used to analyze differences between pre- and postoperative measurements on X-rays within each group. Independent samples t-tests will be used to analyze differences between groups. A p-value < 0.05 is considered statistically significant.
- Conditions
- Osteoarthritis, Knee, Knee Pain Chronic, Arthralgia
- Being tested
- Procedure: HTO using PSI aiming at 55% correction, Procedure: HTO using PSI aiming at 62% correction
- Keywords
- osteotomy, knee, osteoarthritis, 3D print, PSI, High tibial osteotomy, Knee overload, Inertial measurement units, IMU, wearable sensors, gait analysis, accelerometer
- Medical subject headings
- Osteoarthritis, Knee, Arthralgia, Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Procedure: HTO using PSI aiming at 55% correctionProcedure or surgery
HTO using PSI designed to achieve correction to 55% tibial width.
Procedure: HTO using PSI aiming at 62% correctionProcedure or surgery
HTO using PSI designed to achieve correction to 62% tibial width.
| Study group | Role | What they receive |
|---|---|---|
| 55% correction | Experimental | HTO using PSI targeted at 55% correction axis Receives: Procedure: Procedure: HTO using PSI aiming at 55% correction |
| 62% correction | Active comparator | HTO using PSI targeted at 62% correction axis Receives: Procedure: Procedure: HTO using PSI aiming at 62% correction |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knee injury and Osteoarthritis Outcome Score subscore Quality of Life (KOOS QOL), 0-100, 100 best score
Knee related Quality of Life
Measured: 24 months
Secondary outcomes (5)
Knee injury and Osteoarthritis Outcome Score 12 Short form (KOOS-12), 0-100, 100 best score
Knee related pain, symptoms, ADL, QoL and function
Measured: 24 months
Forgotten Joint Score-12(FJS-12), 0-100, 100 best score
Knee related symptoms and function
Measured: 24 months
EuroQol-5D (EQ-5D), index 0-1, 1 best score
Health related quality of life
Measured: 24 months
University of California at Los Angeles activity level (UCLA), 0-10, 10 most active
Activity level score
Measured: 24 months
Ground contact time (milliseconds)
Accelerometer based gait analysis
Measured: 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2023
- Study startNov 2023 (estimated)
- Primary completionOct 2026 (estimated)
- Study completionOct 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Osteoarthritis, KneeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled trial
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Vestre Viken Hospital Trust
- Sponsor type
- University, hospital or other
- Collaborators
- South-Eastern Norway Regional Health Authority, Oslo University Hospital, Lovisenberg Diakonale Hospital
- Responsible party
- Sponsor
- Investigators
- Tor Kjetil Nerhus, MD, PhD, Principal investigator, Martina Hansens Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06134050
- Sponsor's protocol ID
- GS001
- Status last verified
- Nov 2023
- First submitted
- 23 Jun 2023
- Last updated
- 18 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy Using 3D Printed Patient-specific Instrumentation (PSI). An RCT Comparing Correction Aimed at 62% Versus 55%.
- ClinicalTrials.gov ID
- NCT06134050
- Acronym / sponsor ID
- GS001
- Conditions
- Osteoarthritis, Knee, Knee Pain Chronic, Arthralgia
- Keywords
- osteotomy, knee, osteoarthritis, 3D print, PSI, High tibial osteotomy, Knee overload, Inertial measurement units
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Vestre Viken Hospital TrustUniversity, hospital or other
- Collaborators
- South-Eastern Norway Regional Health Authority, Oslo University Hospital, Lovisenberg Diakonale Hospital
- Study start
- Nov 2023 (estimated)
- Primary completion
- Oct 2026 (estimated)
- Study completion
- Oct 2028 (estimated)
- First posted
- 18 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this RCT is to investigate whether high tibial osteotomy using 3D printed patient specific guides aiming at 55% correction is non-inferior to aiming at 62%.
Detailed description
HTO should play a major role in modern treatment algorithms for knee overload and osteoarthritis. By transferring load from the failing/osteoarthritic compartment of the knee to a healthier compartment, HTO can delay or stop the progression of osteoarthritis at an early stage. This can remove pain and increase knee function, making return to work, activities and sport possible. HTO may delay or avoid the need for total knee replacement for >10 years for at least 80% of patients.
The optimal target for the postoperative mechanical axis of the leg is not yet clarified. Both under- and overcorrection can lead to unfavourable results. The classical Fusjisawa´s point of 62%, or approximately 3 deg. of valgus, is still often used as the optimal target, and studies show good clinical results and longevity. With an often accepted accuracy of +/- 3 deg. with conventional methods, the accepted postoperative range of valgus will be from 0 deg. to 6 deg. But the optimal range is possibly much narrower. Recent studies suggest a narrower range and less overcorrection.
3D-printed patient specific instrumentation (PSI) is based on CT of the individual patient´s knee, data simulation of the planned correction and subsequent 3D printed guides for each patient. The PSI design varies, but involves a positioning guide fitting only in position one the proximal tibia, a cutting guidance and a wedge opening guide. PSI seem to improve accuracy to the level of approximately +/- 1 deg. from the preplanned correction and leads to fewer unacceptable outliers compared to the conventional methods available. Improved accuracy has not shown to yield better clinical results.
In the future the target axis should possibly be individualized, based on the pathology treated, gait analyses and data simulations.
Modern gait analysis using wearable accelerator sensors, often referred to as inertial measurement units (IMUs) is rapidly evolving. By coupling individualized and accurate osteotomy with gait analysis using wearable sensors, one could better predict and understand how to normalise each individual patients´ gait pattern and possibly improve patient satisfaction and function after surgery.
By coupling the highly accurate PSI method, an angular stable implant and a composite of outcomes based on radiology, validated patient reported outcome measures and gait analysis, our RCT can investigate if a correction target of 55% is non-inferior to the common 62%.
The study will be designed as a continuous outcome non-inferiority trial where KOOS QoL subscale is used as the primary outcome and the basis for sample size calculation. The Minimal Clinical Important Difference (MCID) for KOOS QoL regarding HTO is 16.5 points. A presumed standard deviation (SD) of 23 points is obtained from a previous study on a similar population. A one-sided t-test power analysis with 2.5% significance level and 80% power level indicates that 31 patients would be needed in each group. In total 70 patients is planned to be included, which takes into account up to 10% dropout rate and some uncertainty regarding the predicted score values.
Statistics:
The primary outcome will be analyzed with a linear mixed model, where the measurements from all time points will be included. The main effect measure will be the between-group difference in change from baseline to two years, which will be estimated with a 95% confidence interval and a P-value for non-inferiority where the null hypothesis is that osteotomy correction to the 55% target is inferior to the correction to the 62% target and the alternative states that it is not. Inferiority is determined by KOOS QOL difference of at least MCID.
Paired samples t-tests will be used to analyze differences between pre- and postoperative measurements on X-rays within each group. Independent samples t-tests will be used to analyze differences between groups. A p-value < 0.05 is considered statistically significant.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| 55% correction | Experimental | Procedure: Procedure: HTO using PSI aiming at 55% correctionHTO using PSI targeted at 55% correction axis |
| 62% correction | Active comparator | Procedure: Procedure: HTO using PSI aiming at 62% correctionHTO using PSI targeted at 62% correction axis |
Who may qualify
- Ages
- 20 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Patients having accepted and signed the informed consent form before surgery
- Patients aged 30-60 years
- Patients with an indication for primary HTO based on anamnestic, clinical and radiological findings leading to the diagnosis of major medial knee compartment overload symptoms
- Mechanical varus axis of 3-9 deg. (calculated on full length weightbearing X-ray (FLWB))
- Correctable angular deformity on the tibia only (medial proximal tibial angle (MPTA) + planned correction < 95 deg. Lateral distal femoral angle (LDFA) <92 deg.)
Key exclusion criteria (11 listed)
- Inflammatory arthritis (Rheumatoid Arthritis, Bechterew arthritis, Psoriatic Arthritis)
- Patients using Prednisolone perorally
- Smokers (need to quit preoperatively)
- Significant overweight (Body Mass Index > 35)
- Earlier fractures in affected leg with fracture malalignment >5 deg.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Procedure: HTO using PSI aiming at 55% correctionHTO using PSI designed to achieve correction to 55% tibial width. | Procedure or surgery | 55% correction |
| Procedure: HTO using PSI aiming at 62% correctionHTO using PSI designed to achieve correction to 62% tibial width. | Procedure or surgery | 62% correction |
Primary outcome
Knee injury and Osteoarthritis Outcome Score subscore Quality of Life (KOOS QOL), 0-100, 100 best score
Time frame: 24 months
Knee related Quality of Life
5 secondary outcomes
Knee injury and Osteoarthritis Outcome Score 12 Short form (KOOS-12), 0-100, 100 best score
Time frame: 24 months
Forgotten Joint Score-12(FJS-12), 0-100, 100 best score
Time frame: 24 months
EuroQol-5D (EQ-5D), index 0-1, 1 best score
Time frame: 24 months
University of California at Los Angeles activity level (UCLA), 0-10, 10 most active
Time frame: 24 months
Ground contact time (milliseconds)
Time frame: 24 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2023.
- Individual participant dataSharing planned: No
Related trials for Osteoarthritis, Knee
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Tor Kjetil Nerhus, MD, PhD principal investigator
Martina Hansens Hospital
Questions about this trial
What is this clinical trial studying?
A study testing Procedure: HTO using PSI aiming at 55% correction and Procedure: HTO using PSI aiming at 62% correction in people with Osteoarthritis, Knee and Knee Pain Chronic, run by Vestre Viken Hospital Trust.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Geir Solberg, MD (+4746821397, geir.solberg@mhh.no), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knee injury and Osteoarthritis Outcome Score subscore Quality of Life (KOOS QOL), 0-100, 100 best score (time frame: 24 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.